Cargando…

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease

Aim: The study aims to test the hypothesis that concentrations of adropin and afamin differ between patients in various stages of chronic kidney disease when compared with healthy controls. The study also investigates the association of the biomarkers (adropin and afamin) with CKD-MBD and traditiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Rupinder, Krishan, Pawan, Kumari, Pratima, Singh, Tanveer, Singh, Varinder, Singh, Ravinder, Ahmad, Sheikh F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572291/ https://www.ncbi.nlm.nih.gov/pubmed/37835901 http://dx.doi.org/10.3390/diagnostics13193158

Ejemplares similares

Novel insights on the role of VCAM-1 and ICAM-1: Potential biomarkers for cardiovascular diseases
por: Kaur, Rupinder, et al.
Publicado: (2022)

Assessment of Serum Concentrations of Adropin, Afamin, and Neudesin in Children with Type 1 Diabetes
por: Polkowska, Agnieszka, et al.
Publicado: (2019)

Clinical significance of parathyroid intervention on CKD-MBD management
por: Ogata, Hiroaki, et al.
Publicado: (2008)

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018)

Gaps between Global Guidelines and Local Practices in CKD-MBD
por: Kim, Gheun-Ho
Publicado: (2014)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
por: Wetmore, James B., et al.
Publicado: (2021)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

Adropin’s Role in Energy Homeostasis and Metabolic Disorders
por: Ali, Ifrah Ismail, et al.
Publicado: (2022)

The vitamin E–binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis
por: Seeber, Beata E., et al.
Publicado: (2010)

Omental torsion: diagnostic challenge in patients with sclerosing cholangitis and inflammatory bowel disease – case report
por: Malik, Neha, et al.
Publicado: (2023)

Airport smoking zones: a prospective public health hazard
por: Singh, Ravinder, et al.
Publicado: (2023)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

Magnesium—A More Important Role in CKD–MBD than We Thought
por: Peride, Ileana, et al.
Publicado: (2022)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
por: Vasco, Raquel F.V., et al.
Publicado: (2021)

Evaluation of first- and third-trimester afamin levels in preeclampsia
por: Gülücü, Selim, et al.
Publicado: (2023)

Study on dengue severity in diabetic and non-diabetic population of tertiary care hospital by assessing inflammatory indicators
por: Singh, Ravinder, et al.
Publicado: (2022)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

Clinical Significance of Neuregulin 4, Afamin, and SERPINB1 in Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance
por: Li, Qian, et al.
Publicado: (2022)

Multiple Eccrine Hidrocystomas in a Patient of Sarcoidosis
por: Singh, Varinder, et al.
Publicado: (2012)

Adropin and Irisin Deficiencies Are Associated With Presence of Diagonal Earlobe Crease in CAD Patients
por: Wei, Na, et al.
Publicado: (2021)

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
por: Köninger, Angela, et al.
Publicado: (2014)

Evaluation of Afamin Level after Bariatric Surgery in Patient with Obesity
por: Demircioglu, Hilmi, et al.
Publicado: (2023)

Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds
por: Singh, Varinder, et al.
Publicado: (2023)

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015
por: Hamano, Takayuki
Publicado: (2017)

Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
por: Köninger, Angela, et al.
Publicado: (2019)

Serum Afamin a Novel Marker of Increased Hepatic Lipid Content
por: Kurdiova, Timea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0equ720havvmvqgc7nepfkphah